These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Clinical significance of histopathologic and ultrastructural pathologic examination in etiological diagnosis of infantile cholestatic diseases]. Zhao RQ; Guan XQ; Luo ZG; Xu HM Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):694-8. PubMed ID: 20943083 [TBL] [Abstract][Full Text] [Related]
8. Inherited metabolic disease of the liver. Taddei T; Mistry P; Schilsky ML Curr Opin Gastroenterol; 2008 May; 24(3):278-86. PubMed ID: 18408455 [TBL] [Abstract][Full Text] [Related]
9. [Recent developments in biopsy diagnosis of early and undefined liver tumors]. Longerich T; Schirmacher P Z Gastroenterol; 2009 Jan; 47(1):30-6. PubMed ID: 19156590 [TBL] [Abstract][Full Text] [Related]
10. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects. Fuda F; Narayan SB; Squires RH; Bennett MJ Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039 [TBL] [Abstract][Full Text] [Related]
11. Cholestatic liver diseases: slow progress in understanding and treating slowly progressive disorders. Vleggaar FP; Van Ooteghem NA; Van Buuren HR; Van Berge Henegouwen GP Scand J Gastroenterol Suppl; 2000; (232):86-92. PubMed ID: 11232499 [TBL] [Abstract][Full Text] [Related]